cholestane-3,5,6-triol has been researched along with dizocilpine maleate in 1 studies
| Studies (cholestane-3,5,6-triol) | Trials (cholestane-3,5,6-triol) | Recent Studies (post-2010) (cholestane-3,5,6-triol) | Studies (dizocilpine maleate) | Trials (dizocilpine maleate) | Recent Studies (post-2010) (dizocilpine maleate) |
|---|---|---|---|---|---|
| 83 | 0 | 20 | 7,741 | 9 | 1,449 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, W; Hu, H; Huang, Y; Leng, T; Liu, A; Qiu, P; Sang, H; Tang, L; Wang, L; Wang, Y; Yan, G; Yin, W; You, X; Zhang, J; Zhou, Y | 1 |
1 other study(ies) available for cholestane-3,5,6-triol and dizocilpine maleate
| Article | Year |
|---|---|
The major cholesterol metabolite cholestane-3β,5α,6β-triol functions as an endogenous neuroprotectant.
Topics: Adult; Animals; Brain Injuries; Cells, Cultured; Central Nervous System; Cholestanols; Disease Models, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Humans; Infarction, Middle Cerebral Artery; Male; Neurons; Neuroprotective Agents; Protein Binding; Rabbits; Rats; Rats, Sprague-Dawley; Spinal Cord Ischemia; Time Factors; Tissue Distribution; Young Adult | 2014 |